Search - tctmd.com

Displaying 141 - 160 of 217

Sort: Relevancy | Date

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Presentation TCT 2013

Renal Denervation with the Medtronic Symplicity Devices: One Simple and One Not-So-Simple Case

Presenter: Robert Whitbourn

October 31, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Presenter: Murray Esler

October 29, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

Presentation TCT 2013

Device and Clinical Trial Update: Symplicity and Spyral (Medtronic)

Presenter: David Kandzari

October 27, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal

September 13, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

News Daily News

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

July 19, 2013

News Daily News

La Denervación Pulmonar es Prometedora contra la Hipertensión Pulmonar Resistente

Yael L. Maxwell

July 19, 2013

News Daily News

EnligHTN I发布：利用多极导管进行去肾交感神经支配术安全、有效

Caitlin E. Cox

July 05, 2013

Advertisement

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Renal Denervation with the Medtronic Symplicity Devices: One Simple and One Not-So-Simple Case

Innovation in Intervention: Perspectives from Industry

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

TCT-58. Persistent and Safe Blood Pressure Lowering Effects of Renal Artery Denervation: Three Year Follow-up From the Symplicity HTN-2 Trial

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Preliminary Data Show Potential of Renal Denervation in Several Settings

Device and Clinical Trial Update: Symplicity and Spyral (Medtronic)

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

La Sensibilidad Baro-refleja podría ayuda a Localizar a Probables Respondedores a la Denervación Renal

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

La Denervación Pulmonar es Prometedora contra la Hipertensión Pulmonar Resistente

EnligHTN I发布：利用多极导管进行去肾交感神经支配术安全、有效

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content